At a glance
- Originator Hisamitsu Pharmaceutical
- Class Antiemetics; Benzofurans; Piperidines; Small molecules
- Mechanism of Action Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Nausea and vomiting
Most Recent Events
- 20 Feb 2006 Discontinued - Preclinical for Emesis in Japan (unspecified route)
- 31 Dec 2001 This compound is still in active development
- 30 Jun 1999 New profile